ReBuilder Medical Technologies secures license to manufacture electronic molluscum contagiosum treatment system

ReBuilder Medical Technologies, Inc. has announced that it has negotiated an exclusive license from White Hall, Inc. for the micronized, amorphous silver ion technology to treat the highly contagious skin disease, Molluscum Contagiosum.

ReBuilder Medical has been manufacturing and distributing this product since 2004 with a non-exclusive license.

Molluscum Contagiosum appears as small warts, boils or pimples that have a translucent core. It is highly contagious and is transmitted sexually in adults. In children it is transmitted through play, swimming pools, shared towels and athletic equipment. Up to now there has been no cure for the disease.

Currently available treatments in doctor's offices include cutting, burning, or freezing off the lesions. This is very painful and leaves the patient open to opportunistic secondary bacterial infections. Prescription ointments are sometimes offered, but these can burn the surrounding skin, leaving this previously healthy tissue vulnerable to cross contamination.

Molluscum Contagiosum is growing quickly all around the world. Pediatricians have reported that approximately 10% of the new patients they see are diagnosed with this skin disease. White Hall, Inc. has developed a non invasive treatment (http://www.molluscum.com/) that uses silver and a small battery powered device to stop the infection painlessly. ReBuilder Medical did the actual development work of this device under an R&D development contract.

"Now that we have observed the efficacy of the system," says Adeyemi Bandele, VP of ReBuilder Medical Technologies, Inc. "We feel that we can make significant improvements to this technology because of our our electronic engineering resources to simplify their design of their electronic accelerator unit and reduce the manufacturing cost. We also feel that we now have the distribution capability to take this consumer based product directly to the physicians in order to reach more users. So we are taking on the product as our own. Part of the license allows us to buy the technology outright in the future.

ReBuilder Medical Technologies, Inc. developed and markets the ReBuilder System for diabetic peripheral neuropathy, a painful nerve condition in the feet and legs.

ReBuilder Medical Technologies, Inc. asserts that the market potential for Molluscum Contagiosum treatments will increase its revenues by significantly in 2007.